Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
334,705,968
-
Total 13F shares
-
47,647
-
Share change
-
+43,917
-
Total reported value
-
$798,562
-
Price per share
-
$16.76
-
Number of holders
-
6
-
Value change
-
+$736,047
-
Number of buys
-
5
-
Number of sells
-
1
Institutional Holders of Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) as of Q1 2025
As of 31 Mar 2025 Telix Pharmaceuticals Ltd - Ordinary Shares (TLX) had 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,647 shares of stock of the company.
Largest 6 holders included ABC ARBITRAGE SA, Private Advisor Group, LLC, MORGAN STANLEY, UBS Group AG, RHUMBLINE ADVISERS, and EverSource Wealth Advisors, LLC.
This table shows 6 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.